Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases
about
Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis ControlFailed attempts at experimental transplantation and transmission of nocturnally-periodic simian Loa from monkey to manGenetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary studyResearch for new drugs for elimination of onchocerciasis in AfricaFactors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of CameroonLoiasis: African eye worm.Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment.Mass treatment of onchocerciasis with ivermectin: should people with epilepsy and/or growth-retardation syndromes be excluded?Age and prior blood feeding of Anopheles gambiae influences their susceptibility and gene expression patterns to ivermectin-containing blood mealsThe life and times of ivermectin - a success story.Overview: Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future.Identification of genes containing ecdysone response elements in the genome of Brugia malayi.Phenotypic and molecular analysis of the effect of 20-hydroxyecdysone on the human filarial parasite Brugia malayiImpact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.Current practices in the management of lymphatic filariasis.Absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events.Central and Peripheral Nervous System Disorders Following Ivermectin Mass Administration: A Descriptive Study Based on the Democratic Republic of Congo Pharmacovigilance System.A novel rapid test for detecting antibody responses to Loa loa infections.Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment.Frequency of the nt230 (del4) MDR1 mutation in Collies and related dog breeds in Germany.Integrated risk mapping and landscape characterisation of lymphatic filariasis and loiasis in South West Nigeria.Rapid integrated clinical survey to determine prevalence and co-distribution patterns of lymphatic filariasis and onchocerciasis in a Loa loa co-endemic area: The Angolan experience.Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus
P2860
Q24800816-21C3F097-2B97-457B-BCA8-88811E6FA098Q24800981-67AAD42F-6D90-4D36-BEA4-CE599B762C10Q24804532-51D14929-7585-4437-831A-D63DC7FD98F1Q28066402-CDECC37C-6B3C-4835-81F2-00A486CB5774Q28553533-D1C0CBBF-641E-48FA-A3B1-C1E2ABCFE10DQ34777473-CCF5D930-60F1-43EC-87FA-918CB182B32AQ35372570-D8DE567D-AB5B-4916-ABC7-8E2586CEC973Q35702158-1FC973A4-8D7D-48CC-B12E-8322511CFFCAQ35809268-8233F2C5-2FF7-4A5D-814F-4DEF962194BBQ35954279-A381B896-1379-427F-B5E4-21D44E64A0DCQ36286101-FDD3E1F0-F39E-488D-8AC2-3DAF5CB15F07Q36287263-3CC7430B-5D32-4E5E-8DC0-C1F8AFDCD283Q36409981-13C8B246-8727-491A-AFAE-461B3FB554F3Q37074803-87436A1C-ECBF-459F-BCDA-995B80C77578Q37362005-98867AD3-F34D-4425-8D98-FC3D31477311Q37503357-B8BCEC6A-8A87-486F-B3F6-B5EC68083A64Q37572997-20024ACA-ECFC-42AE-A88E-AFD36CA9C988Q38732855-981A878F-27F6-48D1-BC08-D48A4B3E6F54Q39346014-B2BC4934-31F8-4204-B293-FFC4DD6BD3C3Q46768706-9676BBB5-3E21-4E4C-BE56-A1BCEB7F8F72Q46772823-DC8C62B6-7800-45A7-BA0B-AD1CCCB72F7DQ46846896-E4300626-A29D-44F7-938B-82F5C7687358Q54963442-C61253A9-5DAB-4AF4-B84C-C94217D27AC9Q55087505-E8E55725-B6B5-4E17-88E3-A2321A87A9E3Q58696166-252A76A1-347D-49BD-B31C-F16286B19E88
P2860
Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Serious adverse events followi ...... ol: a review of reported cases
@ast
Serious adverse events followi ...... ol: a review of reported cases
@en
type
label
Serious adverse events followi ...... ol: a review of reported cases
@ast
Serious adverse events followi ...... ol: a review of reported cases
@en
prefLabel
Serious adverse events followi ...... ol: a review of reported cases
@ast
Serious adverse events followi ...... ol: a review of reported cases
@en
P2860
P1433
P1476
Serious adverse events followi ...... ol: a review of reported cases
@en
P2093
Nana AY Twum-Danso
P2860
P2888
P356
10.1186/1475-2883-2-S1-S3
P478
P577
2003-01-01T00:00:00Z
P6179
1037166286